NYSE: NVO

Novo Nordisk A S (NVO)

Novo Nordisk A S is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker NVO. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
NVO
Exchange
NYSE
SEC CIK
353278
Official filings
SEC EDGAR

Research NVO

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Novo Nordisk A S's stock ticker?

Novo Nordisk A S trades under the ticker symbol NVO on NYSE. Its SEC Central Index Key (CIK) is 353278.

Where can I read Novo Nordisk A S's SEC filings?

The NVO SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Novo Nordisk A S has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze NVO's financial statements?

The NVO Financials page shows Novo Nordisk A S's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does NVO compare with its peers and the market?

The NVO Peer Comparison page lines Novo Nordisk A S up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.